(ALDR) - Earnings & Price History

ALDR: - 10.725, $771.93M, -0.53 (-4.67%)

Sector: Healthcare - Industry: Biotechnology

Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The companys lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperplasia and Cushings diseases; and Clazakizumab, an antibody that has been completed Phase II b clinical trial, which inhibits the pro-inflammatory cytokine interleukin-6 for the treatment of rheumatoid and psoriatic arthritis. In addition, the company has preclinical programs in the discovery phase for various indications. Alder BioPharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Bothell, Washington.Key Statistics

Past ALDR reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-23AMC-0.921.77521.92019.0521.8-8.68%8.87%-0.57%1.05M
2016-10-27AMC-0.8524.826.827.523.427.52.61%-9.82%-7.46%1.90M
2016-07-26AMC-0.7530.4929.4729.929.3432.61.46%1.97%3.46%1.20M
2016-04-28AMC-0.7226.5527.5827.0625.5128.15-1.89%-1.88%-3.73%1.00M
2016-02-23AMC-0.6519.1719.2918.7217.519.92-2.95%2.40%-0.62%934.59K
2015-11-05AMC-0.5136.1637.3335.6634.6836.84-4.47%▲1.40%-3.13%563.79K
2015-08-05AMC-0.445.65444.7444.3943.145.85-0.78%2.85%2.04%174.06K
2015-05-07AMC-0.3937.2330.1929.229.237.62-3.28%27.50%23.32%698.84K
2014-11-03AMCAlder Biopharma-0.250.8816.1718.021916.04195.44%▲-14.89%-10.27%213.10K
2014-08-05AMCAlder Biopharma-0.22-0.415.2215.6615.115.0215.53-3.58%0.79%-2.81%115.20K

Login | Register
Thursday Dec 13, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades